Emmanuel Poteaux, Acting CEO of SATT Conectus, said:“The French biotech ecosystem has been following and supporting AdipoPharma closely for several years. We're excited for Dr. Marion and his team, as ...

Rising numbers of people are needing hospital treatment for side effects from weight loss injections and it may be affecting ...

The use of weight loss drugs without doctor's supervision is not advisable and can lead to serious side effects and ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for diabetes and ...

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

A new study has found that SGLT-2 inhibitor drugs for type 2 diabetes may also reduce the risk of kidney stones and gout. These painful conditions are ...

(NewMediaWire) - November 11, 2024 - DALLAS GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the ...

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...

Drugs that belong to the class of GLP-1 receptor agonists could cause muscle loss ... and slow down digestion. These drugs ...